Stay updated on Aurinia Pharmaceuticals Press Releases
Sign up to get notified when there's something new on the Aurinia Pharmaceuticals Press Releases page.

Latest updates to the Aurinia Pharmaceuticals Press Releases page
- CheckyesterdayChange DetectedAurinia Pharmaceuticals has updated its financial reporting schedule, replacing the upcoming release of third quarter results with a new announcement for the first quarter of 2025.SummaryDifference9%
- Check8 days agoChange DetectedThe webpage now includes recommendations from Glass Lewis and ISS for Aurinia shareholders to vote 'FOR' all proposals at the 2025 Annual General Meeting, while it has removed previous announcements regarding the approval of LUPKYNIS in Japan and new data presented at a conference.SummaryDifference89%
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedThe web page has added a 'Home' section, which may indicate a restructuring of the navigation or content layout.SummaryDifference0.2%
- Check66 days agoChange DetectedAurinia Pharmaceuticals has reported its financial results for the year ending December 31, 2024, and provided an update on corporate progress, while the announcement of its participation in the 2024 Cantor Fitzgerald Global Healthcare Conference has been removed.SummaryDifference10%
- Check73 days agoChange DetectedAurinia Pharmaceuticals has announced the release date for its 2024 fourth quarter and full year financial and operational results, scheduled for February 27, 2025. Additionally, a previous announcement regarding board restructuring has been removed.SummaryDifference9%
- Check116 days agoChange DetectedThe website has added content for the year 2025 while removing all references to 2024.SummaryDifference0.5%
Stay in the know with updates to Aurinia Pharmaceuticals Press Releases
Enter your email address, and we'll notify you when there's something new on the Aurinia Pharmaceuticals Press Releases page.